1Gueertl B, Nohammer C, Hoefler G, et al. Metabolic cardiomyopathies. Int J Exp Pathol,2002,81 (6) :349.
2Helton E, Darragh R,Francis P, et al. Metabolic aspects of myocardial disease and a role of L - carnitine in the treatment of children cardiomy - opathy. Pediatrics, 2000,105(5) : 1260 - 1270.
3Fransen EJ, Maessen JG, Hermens WT, et al. Demonstration of is - chemia - reperfusion injury separate from postoperative infarction in coronary bypass graft patients. Ann Thorac Surg, 1998,65 ( 1 ) :48 - 53.
4Hwang Y C, Bakr S, Ranmasamy R,et al .Relative importance of enhanced slueo- uptake Vel- US attenuation of long- chain acyl eamltines in protecting ischemie myocardittm. Coron Artery Dis,2002,13(6) :313 - 318.
3Helton E, Darragh R, Francis P, et al. Metabolic aspects of myocardial disease and a role of L-carnitine in the treatment of children cardiomyopathy [ J ]. Pediatrics,2000,105 ( 5 ) : 1260-1270.
